These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12464716)

  • 21. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological aspects of therapeutic botulinum toxin preparations].
    Dressler D
    Nervenarzt; 2006 Aug; 77(8):912-21. PubMed ID: 16810528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin type B (Myobloc).
    Baumann L; Black L
    Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of therapeutic botulinum toxin preparations.
    Dressler D; Benecke R
    Disabil Rehabil; 2007 Dec; 29(23):1761-8. PubMed ID: 18033601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin therapy for hyperhidrosis: reduction of injection site pain by nitrous oxide/oxygen mixtures.
    Paracka L; Kollewe K; Dengler R; Dressler D
    J Neural Transm (Vienna); 2015 Sep; 122(9):1279-82. PubMed ID: 25645865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine use of Xeomin in patients previously treated with Botox: long term results.
    Dressler D
    Eur J Neurol; 2009 Dec; 16 Suppl 2():2-5. PubMed ID: 20002739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse diaphragm assay for detection of antibodies against botulinum toxin type B.
    Dressler D; Lange M; Bigalke H
    Mov Disord; 2005 Dec; 20(12):1617-9. PubMed ID: 16078216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin for treatment of dystonia.
    Dressler D
    Eur J Neurol; 2010 Jul; 17 Suppl 1():88-96. PubMed ID: 20590814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of cervical dystonia (torticollis) in adults with botulinum A toxin.
    Metzer WS; Jenkins T
    J Ark Med Soc; 1992 Aug; 89(3):133-4. PubMed ID: 1517180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin therapy for cervical dystonia.
    Jankovic J
    Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A.
    Houser MK; Sheean GL; Lees AJ
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):577-80. PubMed ID: 9598669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of compensatory hyperhidrosis after sympathectomy with botulinum toxin and anticholinergics.
    Karlsson-Groth A; Rystedt A; Swartling C
    Clin Auton Res; 2015 Jun; 25(3):161-7. PubMed ID: 25773586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injections.
    Dubow J; Kim A; Leikin J; Cumpston K; Bryant S; Rezak M
    Mov Disord; 2005 Jul; 20(7):877-80. PubMed ID: 15806568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin-B and the management of hyperhidrosis.
    Baumann LS; Halem ML
    Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin type B: a new therapy for axillary hyperhidrosis.
    Nelson L; Bachoo P; Holmes J
    Br J Plast Surg; 2005 Mar; 58(2):228-32. PubMed ID: 15710119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin therapy of dystonia.
    Dressler D; Adib Saberi F; Rosales RL
    J Neural Transm (Vienna); 2021 Apr; 128(4):531-537. PubMed ID: 33125571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effectiveness of botulinum toxin type A based on severity of palmar hyperhidrosis.
    Ito K; Yanagishita T; Ohshima Y; Tamada Y; Watanabe D
    J Dermatol; 2011 Sep; 38(9):859-63. PubMed ID: 21545498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brachial plexopathy after Botulinum toxin administration for cervical dystonia.
    Sampaio C; Castro-Caldas A; Sales-Luis MI; Alves M; Pinto L; Apolinario P
    J Neurol Neurosurg Psychiatry; 1993 Feb; 56(2):220. PubMed ID: 8382272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.